热门资讯> 正文

Achieve Life Sciences通过新的首席运营官加强领导团队

2025-09-18 23:46

Achieve Life Sciences (NASDAQ:ACHV) promoted Craig Donnelly to COO.
Mr. Donnelly will lead the supply chain and manufacturing activities with the commercial strategy ahead of a product launch in mid-late 2026.
With more than 25 years of biopharmaceutical industry experience, Mr. Donnelly has expertise in both technical development and regulatory CMC at all stages of development.
Mr. Donnelly previously held senior roles in CMC and regulatory functions at companies including NuCana, ICON (formerly Mapi), and F. Hoffman-La Roche.

More on Achieve Life Sciences

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript
Achieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking Cessation
Achieve Life Sciences gets new interim chief medical officer
Achieve Life Sciences' nicotine dependence treatment under FDA review
Seeking Alpha’s Quant Rating on Achieve Life Sciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。